Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FA6S
|
|||
| Former ID |
DIB002760
|
|||
| Drug Name |
Altiratinib
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Deciphera pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H21F3N4O4
|
|||
| Canonical SMILES |
C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F
|
|||
| InChI |
1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)
|
|||
| InChIKey |
GNNDEPIMDAZHRQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1345847-93-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040094) | |||
| REF 2 | Clinical pipeline report, company report or official report of Deciphera Pharmaceuticals. | |||
| REF 3 | Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.Expert Opin Ther Pat. 2017 Jun;27(6):733-751. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.